Daunorubicin therapy in advanced neuroblastoma.
D000380:Agranulocytosis / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001792:Blood Platelets / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D011379:Prognosis
D000970:Antineoplastic Agents; D003630:Daunorubicin